Women who have gynecological conditions that require long-term glucocorticoid therapy are at increased risk for developing GIO. Conditions like autoimmune disorders, severe endometriosis, and certain cases of pelvic inflammatory disease may necessitate the use of these medications. Additionally, the risk of osteoporosis is already higher in women due to factors such as menopause, making the management of bone health even more crucial in this population.
